AFT Pharmaceuticals Limited — Investor Relations & Filings
AFT Pharmaceuticals Limited focuses on the development, licensing, and distribution of pharmaceutical products across a broad range of therapeutic categories. The company’s core portfolio includes pain management, dermatology, eye care, and hospital-based medicines. Its flagship product, Maxigesic, is a patented combination of paracetamol and ibuprofen available in multiple dosage forms and marketed globally. AFT Pharmaceuticals emphasizes research and development to create innovative delivery systems and therapeutic solutions. The company operates through a combination of direct sales in specific regions and international licensing agreements, reaching markets in over 100 countries. Its product range spans over-the-counter (OTC) and prescription medications, targeting both retail pharmacy and clinical environments.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| March Quarter FY 2026 Investor Update | 2026-04-06 | English | |
| Chief Financial Officer update | 2026-03-24 | English | |
| Court of Appeal dismisses PBL Port Wine Stain profit claim | 2026-03-08 | English | |
| December Quarter FY 2026 Investor Update | 2026-01-14 | English | |
| AFT delivers 10th consecutive first half revenue increase | 2025-11-19 | English | |
| AFT CFO Malcolm Tubby to retire; Simon Bosley CFO Designate | 2025-11-18 | English |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
|
Adaptimmune Therapeutics PLC
Commercial-stage biopharma developing TCR T-cell therapies …
|
ADAP | GB | Manufacturing |
AFT Pharmaceuticals Limited via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/66146/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=66146 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=66146 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=66146 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 66146}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for AFT Pharmaceuticals Limited (id: 66146)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.